Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab

Treatment-pattern data suggest that some patients with multiple sclerosis (MS) in the Kingdom of Saudi Arabia (KSA) may not be receiving optimal treatment. A virtual meeting of ten expert Saudi neurologists, held on October 23, 2020, discussed unmet needs in relapsing–remitting MS (RRMS), and the ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Craner, Matthew, Al Malik, Yaser, Babtain, Fawzi A., Alshamrani, Foziah, Alkhawajah, Mona M., Alfugham, Nora, Al-Yafeai, Rumaiza H., Aljarallah, Salman, Makkawi, Seraj, Qureshi, Shireen, Ziehn, Marina, Wahba, Hazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434517/
https://www.ncbi.nlm.nih.gov/pubmed/36048334
http://dx.doi.org/10.1007/s40120-022-00401-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434517/
https://www.ncbi.nlm.nih.gov/pubmed/36048334
http://dx.doi.org/10.1007/s40120-022-00401-4

Ejemplares similares